International Assets Investment Management’s Revolution Medicines RVMD Stock Holding History

International Assets Investment Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.9K	Buy	+106	New	+$15.5K	﹤0.01%	1611

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

International Assets Investment Management's RVMD Position: Q2 2026 in Review

International Assets Investment Management opened a new position in Revolution Medicines (RVMD) in Q2 2026: 106 shares worth $19.9K. The stake represents ﹤0.01% of the portfolio and ranks #1611 among its holdings.

434 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

International Assets Investment Management held 106 shares of Revolution Medicines worth $19.9K as of Q2 2026.
Revolution Medicines was a new International Assets Investment Management position in Q2 2026.
Revolution Medicines made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #1611 holding.
434 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.